HIV/AIDS Vaccines Development
Studies add new findings to HIV/AIDS vaccines development body of knowledge
Published in AIDS Weekly, November 21st, 2005
Study 1: Researchers evaluate the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1 in a recent issue of the Journal of Virology.
"The human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env) complex comprises three gp120 exterior glycoproteins each noncovalently linked to a gp41 transmembrane glycoprotein. Monomeric gp120 proteins can elicit antibodies capable of neutralizing atypically sensitive test viruses in vitro, but these antibodies...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2005-11-21)
More Articles from AIDS Weekly
- Disease Control
Nonbrothel based female sex workers at higher risk of HIV infection than brothel workers - HIV/AIDS Adverse Drug Reaction
Cumulative HAART exposure increases risk of side effect-related morbidity in children - HIV/AIDS Drug Development
Mycophenolic acid inhibits syncytium formation accompanied by reduction of HIV- gp120 expression - HIV/AIDS Epidemiology
HLA class II alleles associated with HIV-1 pathogenesis in Botswana - HIV/AIDS Prognosis
CD4+ levels related to AIDS or death than latest viral load levels in patients on HAART - Business & Finance
Genomics company reports first quarter net loss of $16.7 million - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
